Read the docs
TI-2023-19020 Aliases CVE-2023-37400GHSA-pj8j-wrf5-7mgp

IBM Aspera Faspex privilege escalation

Priority LOW 35CWE-522Published · Updated

Key facts

Attack vector
Local
Privileges required
Low
User interaction
None
Attack complexity
Low
Impact type
Information disclosure
Confidentiality · integrity · availability
High · High · High
Fix status
No fix listed

Attack profile from CVSS 3.1 · CNA. Fix status from CNA. Impact type from CWE-522.

Summary

IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to escalate their privileges due to insecure credential storage. IBM X-Force ID: 259677.

Why it matters now

Exploitation None reported CISA SSVC · not in CISA KEV
EPSS 0.00151 4th percentileScored 2026-11-07
Fix No fix listed No fixed version in the sources yet

SSVC decision points

CISA ADP · SSVC 2.0.3

Exploitation
None
Automatable
No
Technical impact
Total

The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.

Affected products

VendorProductAffected versionsFixed inStatusSource
IBMAspera Faspex5.0.0 – 5.0.7—No fix listedCNA
  • Aspera Faspex VendorIBM Affected 5.0.0 – 5.0.7 Fixed in — No fix listed CNA

CPE configurations NVD · 1

CPEVersionsRoleVendor
cpe:2.3:a:ibm:aspera_faspex:*:*:*:*:*:*:*:*5.0.0 to before 5.0.8VulnerableIBM
  • cpe:2.3:a:ibm:aspera_faspex:*:*:*:*:*:*:*:* Versions 5.0.0 to before 5.0.8 Vulnerable ·IBM

Remediation

No fixed version listed by the sources yet.

Timeline

  1. 2026-10-02 Threatist record created from CVE-2023-37400
  2. 2026-10-03 Alias added: GHSA-pj8j-wrf5-7mgp

References

  • TI-2022-23774 IBM Aspera Faspex code execution KEVCVSS 3.1CRITICAL 9.8
  • TI-2023-12470 IBM Aspera Faspex XML external entity injection CVSS 3.1CRITICAL 9.9
  • TI-2026-12597 OS Command Injection in IBM Aspera Faspex CVSS 3.1CRITICAL 9.1
  • TI-2026-12596 OS command injection in IBM Aspera Faspex CVSS 3.1CRITICAL 9.1
  • TI-2026-12622 Multiple vulnerabilities in IBM Aspera Faspex CVSS 3.1HIGH 8.2
  • TI-2023-19019 IBM Aspera Faspex information disclosure CVSS 3.1CRITICAL 9.8
See all 48 →

Sources